Figure 2From: Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study Distribution of the number of moderate-to-severe adverse events by HIV infection status. Legend for Figure 2: DR-TB = drug resistant tuberculosis.Back to article page